These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 1673953

  • 1. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
    Bardhan KD, Naesdal J, Bianchi Porro G, Petrillo M, Lazzaroni M, Hinchliffe RF, Thompson M, Morris P, Daly MJ, Carroll NJ.
    Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
    [Abstract] [Full Text] [Related]

  • 2. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
    Chelvam P, Wong EC.
    J Gastroenterol Hepatol; 1989 Apr; 4 Suppl 2():75-81. PubMed ID: 2577478
    [Abstract] [Full Text] [Related]

  • 3. Is there any acid peptic disease that is refractory to proton pump inhibitors?
    Bardhan KD.
    Aliment Pharmacol Ther; 1993 Apr; 7 Suppl 1():13-24, discussion 29-31. PubMed ID: 8490075
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of the H+/K+-adenosine triphosphatase inhibitor omeprazole in peptic ulcer.
    de Bruijne JW, Snel P, Lamers CB.
    Digestion; 1989 Apr; 44 Suppl 1():25-30. PubMed ID: 2691308
    [Abstract] [Full Text] [Related]

  • 5. Omeprazole in the treatment of peptic ulcers resistant to H2-receptor antagonists.
    Guerreiro AS, Neves BC, Quina MG.
    Aliment Pharmacol Ther; 1990 Jun; 4(3):309-13. PubMed ID: 1983325
    [Abstract] [Full Text] [Related]

  • 6. Double blind comparative study of omeprazole and ranitidine in patients with duodenal or gastric ulcer: a multicentre trial. Cooperative study group.
    Gut; 1990 Jun; 31(6):653-6. PubMed ID: 2199347
    [Abstract] [Full Text] [Related]

  • 7. Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists.
    Tytgat GN, Lamers CB, Hameeteman W, Jansen JM, Wilson JA.
    Aliment Pharmacol Ther; 1987 Feb; 1(1):31-8. PubMed ID: 2908747
    [Abstract] [Full Text] [Related]

  • 8. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S, Långström G, Rikner L, Carlsson R, Naesdal J.
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [Abstract] [Full Text] [Related]

  • 9. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer.
    Walan A, Bader JP, Classen M, Lamers CB, Piper DW, Rutgersson K, Eriksson S.
    N Engl J Med; 1989 Jan 12; 320(2):69-75. PubMed ID: 2643037
    [Abstract] [Full Text] [Related]

  • 10. Histology of gastric biopsies from peptic ulcer patients before and after short-term treatment with omeprazole or H2-receptor antagonists.
    Helander HF, Simonsson M, Sundler F, Rutgersson K, Helander KG, Eriksson S.
    Virchows Arch A Pathol Anat Histopathol; 1990 Jan 12; 417(4):305-9. PubMed ID: 1978433
    [Abstract] [Full Text] [Related]

  • 11. The clinical utility and safety of omeprazole.
    Walan A.
    Scand J Gastroenterol Suppl; 1989 Jan 12; 166():140-4; discussion 145. PubMed ID: 2574908
    [Abstract] [Full Text] [Related]

  • 12. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
    McTavish D, Buckley MM, Heel RC.
    Drugs; 1991 Jul 12; 42(1):138-70. PubMed ID: 1718683
    [Abstract] [Full Text] [Related]

  • 13. Double blind multicentre comparison of omeprazole 20 mg once daily versus ranitidine 150 mg twice daily in the treatment of cimetidine or ranitidine resistant duodenal ulcers.
    Delchier JC, Isal JP, Eriksson S, Soule JC.
    Gut; 1989 Sep 12; 30(9):1173-8. PubMed ID: 2680793
    [Abstract] [Full Text] [Related]

  • 14. Omeprazole in the management of refractory duodenal ulcer.
    Bardhan KD.
    Scand J Gastroenterol Suppl; 1989 Sep 12; 166():63-73. PubMed ID: 2574910
    [Abstract] [Full Text] [Related]

  • 15. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Sep 12; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 16. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
    Yeomans ND, Tulassay Z, Juhász L, Rácz I, Howard JM, van Rensburg CJ, Swannell AJ, Hawkey CJ.
    N Engl J Med; 1998 Mar 12; 338(11):719-26. PubMed ID: 9494148
    [Abstract] [Full Text] [Related]

  • 17. [Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists].
    Asaka M, Kato M, Sato Y, Miyazaki T.
    Nihon Rinsho; 1992 Jan 12; 50(1):104-10. PubMed ID: 1347322
    [Abstract] [Full Text] [Related]

  • 18. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.
    Am J Gastroenterol; 1997 Mar 12; 92(3):429-37. PubMed ID: 9068463
    [Abstract] [Full Text] [Related]

  • 19. [Omeprazole in the therapy of acid-induced diseases].
    Simon B, Dammann HG, Müller P.
    Z Gastroenterol; 1987 Aug 12; 25 Suppl 3():146-51. PubMed ID: 2889299
    [Abstract] [Full Text] [Related]

  • 20. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E.
    Wien Med Wochenschr; 1983 Aug 12; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.